2021
DOI: 10.1016/j.amepre.2020.08.014
|View full text |Cite
|
Sign up to set email alerts
|

Predictive Factors for a New Positive Nasopharyngeal Swab Among Patients Recovered From COVID-19

Abstract: on behalf of Gemelli Against COVID-19 Post-Acute Care Team Introduction: As an emerging infectious disease, the clinical and virologic course of COVID-19 requires better investigation. The aim of this study is to identify the potential risk factors associated with persistent positive nasopharyngeal swab real-time reverse transcription-polymerase chain reaction tests in a large sample of patients who recovered from COVID-19. Methods: After the acute phase of SARS-CoV-2 epidemic infection, the Fondazione Policli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
33
2

Year Published

2021
2021
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 36 publications
(35 citation statements)
references
References 24 publications
0
33
2
Order By: Relevance
“…During the second hospitalization, no RP patients showed any new symptoms, 78·31% showed further improved on chest CT scan compared with the first discharge. None of the close contacts developed COVID-19 Peng et al [117] China Case series 9 5 7·2 ± 4·8 14/38 positive positive positive Family cluster infection, higher WBC count, and longer plasma prothrombin time (PT) are the early risk factors for RP in recovered COVID‐19 children Landi et al [115] Italy Case series 10 12 56·4 ± 15·7 22/131 14 d positive Persistent sore throat (prevalence ratio=6·50, 95% CI 1·38, 30·6) and symptoms of rhinitis (prevalence ratio=3·72, 95% CI 1·10, 12·5) were risk factors for retesting positive for SARS-CoV-2 Zhou et al [121] China Case series 16 7 51·0(42–58) 23/368 14 d positive Using multivariate Cox regression analysis, risk factors associated with RP included a higher ratio of lymphocyte/white blood cell on admission, lower peak temperature during hospitalization, and the presence of comorbidities, particularly hypertension or chronic respiratory system diseases. Antivirus treatment with arbidol was associated with a lower likelihood of RP Huang et al [114] China Case series 41 28 69/417 14 d positive …”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…During the second hospitalization, no RP patients showed any new symptoms, 78·31% showed further improved on chest CT scan compared with the first discharge. None of the close contacts developed COVID-19 Peng et al [117] China Case series 9 5 7·2 ± 4·8 14/38 positive positive positive Family cluster infection, higher WBC count, and longer plasma prothrombin time (PT) are the early risk factors for RP in recovered COVID‐19 children Landi et al [115] Italy Case series 10 12 56·4 ± 15·7 22/131 14 d positive Persistent sore throat (prevalence ratio=6·50, 95% CI 1·38, 30·6) and symptoms of rhinitis (prevalence ratio=3·72, 95% CI 1·10, 12·5) were risk factors for retesting positive for SARS-CoV-2 Zhou et al [121] China Case series 16 7 51·0(42–58) 23/368 14 d positive Using multivariate Cox regression analysis, risk factors associated with RP included a higher ratio of lymphocyte/white blood cell on admission, lower peak temperature during hospitalization, and the presence of comorbidities, particularly hypertension or chronic respiratory system diseases. Antivirus treatment with arbidol was associated with a lower likelihood of RP Huang et al [114] China Case series 41 28 69/417 14 d positive …”
Section: Resultsmentioning
confidence: 99%
“…Nineteen studies ( n = 101) [ 16 , 18 , 22 – 25 , 32 , 35 , 36 , 49 – 51 , 59 , 73 , 76 , 97 , 104 , 107 , 115 ] showed that discharged patients had no symptoms when the nucleic acid test was positive. Among 55 studies, 1054 RP patients had symptoms, cough (19·82%) [ 20 , 26 , 29 – 31 , 34 , 38 , 42 , 44 , 49 , 52 , 60 , 62 , 63 , 66 , 67 , 69 , 71 , 74 , 78 , 81 , 83 85 , 88 , 89 , 91 , 94 , 95 , 98 , 101 , 103 , 106 , 108 , 110 , 119 , 121 , 125 , 127 , 130 ] and fever (14·99%) [ 20 , 28 , 29 , 41 , 44 , 46 , 49 , 52 , 67 ,…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…There are few prospective studies with assessments beyond 12 weeks [31,[35][36][37][38][39] fulfilling the NHS current criteria for post-COVID-19 syndrome. [40][41][42][43][44][45][46][47][48][49][50] or outpatients [51][52][53][54][55][56], evaluated between 4 and 12 weeks after diagnosis. The mean of the presentation of symptoms appears considering all the studies that contribute.…”
Section: Clinical Manifestations Of Post-covid-19 Syndromementioning
confidence: 99%